Next Article in Journal
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study
Next Article in Special Issue
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations
Previous Article in Journal
Adverse Events in Targeted Therapy for Unresectable Hepatocellular Carcinoma Predict Clinical Outcomes
Previous Article in Special Issue
Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative Disorder: A Real-World Experience
 
 
Article

Article Versions Notes

Cancers 2024, 16(18), 3149; https://doi.org/10.3390/cancers16183149
Action Date Notes Link
article html file updated 13 September 2025 17:32 CEST Update https://www.mdpi.com/2072-6694/16/18/3149/html
article html file updated 25 August 2025 01:36 CEST Update -
article html file updated 26 June 2025 19:18 CEST Update -
article html file updated 14 September 2024 07:19 CEST Original file -
article supplementary file uploaded. 14 September 2024 07:15 CEST - https://www.mdpi.com/2072-6694/16/18/3149#supplementary
article pdf uploaded. 14 September 2024 07:15 CEST Version of Record https://www.mdpi.com/2072-6694/16/18/3149/pdf
article xml uploaded. 14 September 2024 07:15 CEST Update https://www.mdpi.com/2072-6694/16/18/3149/xml
article xml file uploaded 14 September 2024 07:15 CEST Original file -
Back to TopTop